Archives
-
Caffeine Workflows for Cancer and Metabolism
2026-08-20
Build reproducible Caffeine assays for cancer cell line inhibition, energy metabolism modulation, and neurobiology without overlooking solvent, stability, or endpoint controls. This guide also translates assay-design lessons from a recent ALDH2 activator study while clearly separating evidence for Caffeine from findings on unrelated cardiovascular compounds.
-
Deferasirox Workflows for Iron-Dependent Cancer Models
2026-08-19
Learn how to use Deferasirox as an oral iron chelator and controlled laboratory perturbation of labile iron, mitochondrial ROS, and ferroptosis-related phenotypes. This workflow separates validated iron-overload applications from exploratory HCC experiments built around the METTL16-SENP3-LTF axis.
-
Metoprolol Tartrate: A Selectivity-First Assay Framework
2026-08-19
Metoprolol Tartrate is a β1-adrenergic blocking agent for dissecting cardiac signaling with controlled receptor selectivity. This guide translates hematopoietic regeneration evidence into practical assay-design decisions for cardiovascular research, hypertension research, and carefully bounded cross-domain studies.
-
EZ Cap Cy5 Firefly Luciferase mRNA Workflow
2026-08-18
Build a clearer mRNA delivery workflow by pairing Cy5-based intracellular tracking with functional Firefly Luciferase expression. This dual-reporter design helps distinguish poor uptake from failed endosomal escape, weak translation, or excessive cellular stress in mammalian and in vivo studies.
-
EdU Cell Proliferation Kit: Cell-State Readouts
2026-08-18
The EdU Cell Proliferation Kit enables a sensitive 5-ethynyl-2'-deoxyuridine proliferation assay for measuring DNA synthesis. This guide connects click-chemistry signal generation with mechanism-aware interpretation in rheumatoid arthritis and translational drug research.
-
SEC-seq Reveals High VEGF-A Secretion States
2026-08-17
The reference study introduces secretion encoded single-cell sequencing (SEC-seq), a nanovial-based workflow that connects extracellular VEGF-A secretion with transcriptomes from individual mesenchymal stromal cells. Its central finding is that secretion varies substantially between cells and is only weakly predicted by VEGFA transcript abundance, highlighting the value of functional single-cell measurements.
-
Indomethacin in Adipose Inflammation Research
2026-08-17
Indomethacin is more than a conventional cyclooxygenase inhibitor. Its Cox-1-preferential profile, PPAR activity, and potential effects on cholesterol-rich membrane domains create a useful mechanistic framework for studying how inflammatory signaling intersects with adipocyte differentiation, thermogenesis, lipid metabolism, and membrane organization. Building on recent evidence that SEMA3E promotes beige adipocyte differentiation through Wnt/β-catenin signaling, this article outlines how Indomethacin can be deployed as a carefully controlled translational research tool rather than treated as a single-pathway reagent.
-
Patient-Derived 3D Spheroids in Prostate Cancer
2026-08-16
Linxweiler and colleagues established viable three-dimensional spheroids from radical prostatectomy specimens, creating a clinically relevant model for organ-confined prostate cancer. The cultures retained key epithelial and prostate cancer markers, supported cryopreservation and long-term maintenance, and revealed stronger responses to bicalutamide and enzalutamide than to docetaxel or abiraterone under the tested conditions.
-
Phage-Layer Interferometry for Phage Therapy
2026-08-15
The reference study introduces phage-layer interferometry (PLI), a time-resolved, label-free platform for screening therapeutic bacteriophages and detecting bacteria in complex media. By distinguishing phage binding from subsequent lysis and operating in opaque samples such as baby formula, PLI addresses limitations of plaque-based and bulk optical assays.
-
Digoxin Assay Reliability: 5 Lab Scenarios
2026-08-14
This scenario-driven guide shows how Digoxin, SKU B7684, can support better-controlled cell viability, cytotoxicity, cardiac, and chikungunya virus experiments. It connects mechanism, DMSO stock preparation, cell-type limitations, data interpretation, and supplier documentation to practical laboratory decisions.
-
Tin Mesoporphyrin IX (chloride) in HO Assays
2026-08-14
Learn how Tin Mesoporphyrin IX (chloride), SKU C5606, can help researchers distinguish heme oxygenase pathway effects from nonspecific changes in cell viability, proliferation, and cytotoxicity assays. This scenario-based guide covers mechanism, solvent compatibility, protocol design, interpretation, and practical supplier-selection criteria.
-
Coumestrol-Driven Ferroptosis in RA Synoviocytes
2026-08-13
The reference study identifies a TRIM3–PMAIP1 regulatory axis through which Coumestrol promotes ferroptosis in rheumatoid arthritis fibroblast-like synoviocytes. Its findings connect mitochondrial protein stability with reduced synoviocyte proliferation and inflammatory cytokine production, while also defining important limits for translating this in vitro mechanism to therapeutic research.
-
Mycobacterium tuberculosis WecA: Expression and Kinetics
2026-08-13
Zhao and colleagues establish a practical route to obtain active Mycobacterium tuberculosis WecA, an otherwise difficult 11-transmembrane-domain enzyme and potential anti-tuberculosis target. Their combination of tunable expression, affinity purification, mass-spectrometric identification, UMP-based activity detection, and competitive inhibition analysis creates a foundation for mechanistic studies and WecA inhibitor discovery.
-
GSH-Responsive MOF Nanoparticles for Melanoma Therapy
2026-08-12
Hao et al. developed a glutathione-responsive metal–organic framework nanoparticle that combines indocyanine green photothermal therapy with AUNP12-mediated PD-1/PD-L1 checkpoint blockade. The study shows how stimulus-responsive release and near-infrared irradiation can be integrated to promote tumor-cell killing, dendritic-cell maturation, and immune activation, while also highlighting the translational questions that remain.
-
Digoxin Workflows for Cardiac and Antiviral Research
2026-08-12
Build mechanism-centered assays around Digoxin, from Na+/K+ ATPase perturbation and calcium signaling to cell-type-specific chikungunya studies. This workflow pairs formulation guidance with disease-state pharmacokinetic thinking, helping researchers distinguish true biology from vehicle, exposure, and matrix effects.